These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Genetic risk factors for hepatic fibrosis in chronic liver diseases]. Wasmuth HE; Lammert F; Matern S Med Klin (Munich); 2003 Dec; 98(12):754-62. PubMed ID: 14685677 [TBL] [Abstract][Full Text] [Related]
8. Liver fibrosis - mouse models and relevance in human liver diseases. Mederacke I Z Gastroenterol; 2013 Jan; 51(1):55-62. PubMed ID: 23315652 [TBL] [Abstract][Full Text] [Related]
9. Fibrosis in the liver: acute protection and chronic disease. Lee Y; Friedman SL Prog Mol Biol Transl Sci; 2010; 97():151-200. PubMed ID: 21074733 [TBL] [Abstract][Full Text] [Related]
10. Myofibroblast - like cells and liver fibrogenesis: Emerging concepts in a rapidly moving scenario. Parola M; Marra F; Pinzani M Mol Aspects Med; 2008; 29(1-2):58-66. PubMed ID: 18022682 [TBL] [Abstract][Full Text] [Related]
11. Hepatic fibrogenesis: from within and outwith. Henderson NC; Forbes SJ Toxicology; 2008 Dec; 254(3):130-5. PubMed ID: 18824072 [TBL] [Abstract][Full Text] [Related]
12. Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues. Parola M; Pinzani M Mol Aspects Med; 2019 Feb; 65():37-55. PubMed ID: 30213667 [TBL] [Abstract][Full Text] [Related]
13. Hepatic fibrogenesis: the puzzle of interacting cells, fibrogenic cytokines, regulatory loops, and extracellular matrix molecules. Gressner AM Z Gastroenterol; 1992 Mar; 30 Suppl 1():5-16. PubMed ID: 1449018 [TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of hepatic fibrosis in non-alcoholic steatohepatitis. Rombouts K; Marra F Dig Dis; 2010; 28(1):229-35. PubMed ID: 20460917 [TBL] [Abstract][Full Text] [Related]
15. Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell-to-cell interaction and transition. Svegliati-Baroni G; De Minicis S; Marzioni M Liver Int; 2008 Sep; 28(8):1052-64. PubMed ID: 18783548 [TBL] [Abstract][Full Text] [Related]
16. Development and Regression of Cirrhosis. Saffioti F; Pinzani M Dig Dis; 2016; 34(4):374-81. PubMed ID: 27170391 [TBL] [Abstract][Full Text] [Related]
17. What's new in liver fibrosis? The origin of myofibroblasts in liver fibrosis. Iwaisako K; Brenner DA; Kisseleva T J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2(Suppl 2):65-8. PubMed ID: 22320919 [TBL] [Abstract][Full Text] [Related]
18. Protease-activated receptor 2 promotes experimental liver fibrosis in mice and activates human hepatic stellate cells. Knight V; Tchongue J; Lourensz D; Tipping P; Sievert W Hepatology; 2012 Mar; 55(3):879-87. PubMed ID: 22095855 [TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of liver fibrosis: role of oxidative stress. Poli G Mol Aspects Med; 2000 Jun; 21(3):49-98. PubMed ID: 10978499 [TBL] [Abstract][Full Text] [Related]
20. The epidermal growth factor receptor ligand amphiregulin participates in the development of mouse liver fibrosis. Perugorria MJ; Latasa MU; Nicou A; Cartagena-Lirola H; Castillo J; Goñi S; Vespasiani-Gentilucci U; Zagami MG; Lotersztajn S; Prieto J; Berasain C; Avila MA Hepatology; 2008 Oct; 48(4):1251-61. PubMed ID: 18634036 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]